Inhibition of ferroptosis alleviates atherosclerosis and foam cell formation by regulating lipid metabolism via AMPK activation
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.114553 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Yunfan Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Second Hospital of Jilin University, Changchun, Jilin 130041, China. Hauptthemen laut MEDLINE: Ferroptosis, Foam Cells, Atherosclerosis, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Jilin Provincial Natural Science Foundation, Jilin Province Department of Finance, National Natural Science Foundation of China.
Abstract (Originalsprache)
Atherosclerosis (AS) is a lipid disorder characterised by lipid accumulation in the aortic wall and foam cell formation. Recent studies have shown that excess iron accelerates AS progression and foam cell formation by inducing ferroptosis. GPx4, an anti-erroptotic protein, promotes SCARB1 expression, which inhibits macrophage foam cell formation by interacting with HDL. Thus, a complex association exists between ferroptosis and lipid metabolism. However, the underlying mechanisms remain unclear. AMPK signalling is a key regulator of metabolism and is involved in the regulation of ferroptosis. In this study, we used the ferroptosis inhibitor ferrostatin-1 (Fer-1) to assay the effect of ferroptosis inhibition on AS and foam cell formation and to investigate the underlying mechanism. Our results showed that Fer-1 alleviated AS lesions and foam cell formation both in vivo and in vitro. Additionally, Fer-1 reduced iron content and lipid accumulation in oxidized low-density lipoprotein (ox-LDL)-treated macrophages by upregulating the levels of FTH, GPx4, and SCARB1 via AMPK activation. The inhibition of AMPK reduces the effect of Fer-1 on iron and lipid accumulation in macrophages, which may contribute to a deeper understanding of the pathological process of AS and provide a therapeutic target for AS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Second Hospital of Jilin University, Changchun, Jilin 130041, China.
- Department of Clinical Laboratory, Second Hospital of Jilin University, No. 218 Ziqiang Street, Changchun 130041, China.
- Department of Cardiology, Second Hospital of Jilin University, Changchun, Jilin 130041, China. Electronic address: wangjunnan@jlu.edu.cn.
- Department of Cardiology, Second Hospital of Jilin University, Changchun, Jilin 130041, China. Electronic address: yanuu@jlu.edu.cn.
Förderung
- Jilin Provincial Natural Science Foundation
- Jilin Province Department of Finance
- National Natural Science Foundation of China
Zitieren
APA
Yang, Y., Chen, Z., Song, D., Wu, J., Wang, J., & YouyouYan (2025). Inhibition of ferroptosis alleviates atherosclerosis and foam cell formation by regulating lipid metabolism via AMPK activation. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114553
Vancouver
Yang Y, Chen Z, Song D, Wu J, Wang J, YouyouYan. Inhibition of ferroptosis alleviates atherosclerosis and foam cell formation by regulating lipid metabolism via AMPK activation. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114553
BibTeX
@article{Yang2025,
author = {Yang, Yunfan and Chen, Zhenzhen and Song, Dandan and Wu, Junduo and Wang, Junnan and YouyouYan},
title = {Inhibition of ferroptosis alleviates atherosclerosis and foam cell formation by regulating lipid metabolism via AMPK activation},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.114553}
}
EUVIMED